Search research articles
Contact Us
Filters
Showing results (231-240 of 239) with videos related to
Page
of 24
Sort By:
You have reached the last page of results.
This site can display upto 239 results.
Gynecologic Oncology
|
August 15, 2025
Evaluation of the combination lenvatinib and pembrolizumab in endometrial cancer; a real world multi-institutional review of practice patterns, efficacy and tolerability
Bradley R Corr, Samantha M Thomas, Paulina J Haight, et al.
Cancer
|
December 8, 2016
Synuclein-γ in uterine serous carcinoma impacts survival: An NRG Oncology/Gynecologic Oncology Group study
Abigail D Winder, Kruti P Maniar, Jian-Jun Wei, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society
|
September 25, 2024
Patient-reported outcomes in the subpopulation of patients with mismatch repair-deficient/microsatellite instability-high primary advanced or recurrent endometrial cancer treated with dostarlimab plus chemotherapy compared with chemotherapy alone in the ENGOT-EN6-NSGO/GOG3031/RUBY trial
Giorgio Valabrega, Matthew A Powell, Sakari Hietanen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 14, 2019
A Randomized Phase II Trial of Epigenetic Priming with Guadecitabine and Carboplatin in Platinum-resistant, Recurrent Ovarian Cancer
Amit M Oza, Ursula A Matulonis, Angeles Alvarez Secord, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society
|
August 11, 2020
Adjuvant treatment improves overall survival in women with high-intermediate risk early-stage endometrial cancer with lymphovascular space invasion
Ji Son, Laura M Chambers, Caitlin Carr, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society
|
July 2, 2026
Poly(adenosine diphosphate-ribose) polymerase inhibitor maintenance therapy with niraparib in patients with primary advanced or recurrent endometrial cancer receiving dostarlimab plus chemotherapy
Matthew A Powell, Sharad Ghamande, Lars C Hanker, et al.
Gynecologic Oncology
|
January 18, 2020
Adjuvant therapy for early stage, endometrial cancer with lymphovascular space invasion: Is there a role for chemotherapy?
Anna L Beavis, Ting-Tai Yen, Rebecca L Stone, et al.
Gynecologic Oncology
|
April 9, 2024
Disease progression, survival, and molecular disparities in Black and White patients with endometrioid endometrial carcinoma in real-world registries and GOG/NRG oncology randomized phase III clinical trials
Zachary A Kopelman, Chunqiao Tian, Jordyn Tumas, et al.
The Lancet. Gastroenterology & Hepatology
|
August 4, 2023
Surgical versus non-surgical management for patients with malignant bowel obstruction (S1316): a pragmatic comparative effectiveness trial
Robert S Krouse, Garnet L Anderson, Kathryn B Arnold, et al.
Page
of 24
Search research articles
Search
Showing results (231-240 of 239) with videos related to
Sort By:
Page
of 24
You have reached the last page of results.
This site can display upto 239 results.
Gynecologic Oncology
|
August 15, 2025
Evaluation of the combination lenvatinib and pembrolizumab in endometrial cancer; a real world multi-institutional review of practice patterns, efficacy and tolerability
Bradley R Corr, Samantha M Thomas, Paulina J Haight, et al.
Cancer
|
December 8, 2016
Synuclein-γ in uterine serous carcinoma impacts survival: An NRG Oncology/Gynecologic Oncology Group study
Abigail D Winder, Kruti P Maniar, Jian-Jun Wei, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society
|
September 25, 2024
Patient-reported outcomes in the subpopulation of patients with mismatch repair-deficient/microsatellite instability-high primary advanced or recurrent endometrial cancer treated with dostarlimab plus chemotherapy compared with chemotherapy alone in the ENGOT-EN6-NSGO/GOG3031/RUBY trial
Giorgio Valabrega, Matthew A Powell, Sakari Hietanen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 14, 2019
A Randomized Phase II Trial of Epigenetic Priming with Guadecitabine and Carboplatin in Platinum-resistant, Recurrent Ovarian Cancer
Amit M Oza, Ursula A Matulonis, Angeles Alvarez Secord, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society
|
August 11, 2020
Adjuvant treatment improves overall survival in women with high-intermediate risk early-stage endometrial cancer with lymphovascular space invasion
Ji Son, Laura M Chambers, Caitlin Carr, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society
|
July 2, 2026
Poly(adenosine diphosphate-ribose) polymerase inhibitor maintenance therapy with niraparib in patients with primary advanced or recurrent endometrial cancer receiving dostarlimab plus chemotherapy
Matthew A Powell, Sharad Ghamande, Lars C Hanker, et al.
Gynecologic Oncology
|
January 18, 2020
Adjuvant therapy for early stage, endometrial cancer with lymphovascular space invasion: Is there a role for chemotherapy?
Anna L Beavis, Ting-Tai Yen, Rebecca L Stone, et al.
Gynecologic Oncology
|
April 9, 2024
Disease progression, survival, and molecular disparities in Black and White patients with endometrioid endometrial carcinoma in real-world registries and GOG/NRG oncology randomized phase III clinical trials
Zachary A Kopelman, Chunqiao Tian, Jordyn Tumas, et al.
The Lancet. Gastroenterology & Hepatology
|
August 4, 2023
Surgical versus non-surgical management for patients with malignant bowel obstruction (S1316): a pragmatic comparative effectiveness trial
Robert S Krouse, Garnet L Anderson, Kathryn B Arnold, et al.
Page
of 24